Explorer les evidences

311 genomesA total of 311 SARS-CoV-2 genomes were generated from samples collected in coastal Kenya between 17th March and 31st July 2020.

KenyaCOVID-19observé 17th March and 31st July 2020publié 2021Nature communicationseurope_pmcdocument de 2 observations

63 %Lineage B.1 accounted for 723 out of 1139 sequenced SARS-CoV-2 infections in Coastal Kenya, representing 63% of all sequenced cases.

KenyaCOVID-19publié 2022eLifeeurope_pmcdocument de 6 observations

1 %Two (1%) patients with malaria co-infection and three (1%) without malaria died.

KenyaCOVID-19 · paludismepublié 2026The Lancet. Global healthPubMeddocument de 8 observations

39,9 %If SARS-CoV-2 self-testing were available, 39.9% of participants would be likely to use it.

KenyaCOVID-19observé August 2021publié 2022International journal of public healtheurope_pmcdocument de 6 observations

1,56 aORSRI patients presenting with sore throat were more likely to have SARS-CoV-2 infection compared to those who did not, with an adjusted odds ratio of 1.56.

KenyaCOVID-19observé July 2022 to October 2023publié 2026VaccinePubMeddocument de 8 observations

27,9 %SARS-CoV-2 test results were positive in 2,364 (27.9%) of the 8,471 patients that underwent testing.

KenyaCOVID-19observé May 2020 to December 2022publié 2024BMC infectious diseasesPubMeddocument de 3 observations

28 daysAntibody-neutralising potencies peaked at day 28 after PCR testing.

KenyaCOVID-19publié 2023Wellcome open researcheurope_pmcdocument de 4 observations

50 %Seroreversion occurred in about half of mothers and infants.

KenyaCOVID-19observé between May 1, 2020-February 1, 2022publié 2023PloS onePubMeddocument de 8 observations

2,15 aPRAmong participants in Kenya, Uganda, Tanzania, and Nigeria between 19 July 2022 and 1 March 2024, adjusted prevalence ratio for SARS-CoV-2 infection was 2.15 during the omicron wave compared to non-wave periods.

Kenya · Nigeria · Ouganda · TanzanieCOVID-19observé 19 July 2022 to 1 March 2024publié 2025BMC infectious diseasesPubMeddocument de 8 observations

108 introductionsOne hundred eight SARS-CoV-2 introductions in Kenya between March 2020 and September 2022 were associated with the Alpha variant.

KenyaCOVID-19observé March 2020 – September 2022publié 2022The genomic epidemiology of SARS-CoV-2 variants of concern in Kenyaeurope_pmcdocument de 8 observationsDOI 10.1101/2022.10.26.22281446

2,73 odds_ratioThe odds of developing COVID-19 symptoms were higher among cases with underlying conditions (odds ratio = 2.73, P < 0.001).

KenyaCOVID-19publié 2022Journal of global healthPubMeddocument de 24 observations

31,1 %31.1% of pregnant women in Kenya were concerned about COVID-19 vaccine effectiveness.

KenyaCOVID-19observé 2022publié 2024International journal of environmental research and public healtheurope_pmcdocument de 5 observationsDOI 10.3390/ijerph21010098

45 %45% of the RT-PCR positive samples were paired with positive serum IgG antibody samples in the Coastal part of Kenya between 17th March 2020 and 30th June 2021.

KenyaCOVID-19observé 17th March 2020 to 30th June 2021publié 2022Wellcome open researcheurope_pmcdocument de 10 observations

30 %An estimated 30–50% of residents in the major urban counties of Kenya were infected during the first wave of SARS-CoV-2 transmission.

KenyaCOVID-19observé up to the end of September 2020publié 2021Wellcome open researcheurope_pmcdocument de 2 observations

10,5 %A minority of participants (10.5%) had ever tested for SARS-CoV-2.

KenyaCOVID-19observé August 2021publié 2022International journal of public healtheurope_pmcdocument de 6 observations

4 %The prevalence of detectable SARS-CoV-2 antibodies was 4% among participants without HIV in Western Kenya.

KenyaCOVID-19 · VIH/sidaobservé January through March 2020publié 2021AIDS (London, England)PubMeddocument de 3 observations

28,5 %The most common comorbidities among patients with laboratory-confirmed COVID-19 were hypertension (28.5%), diabetes mellitus (26.1%), and heart disease (4.1%).

KenyaCOVID-19publié 2022PloS onePubMeddocument de 7 observations

49,2 yearsIn the sample of 582 patients admitted with laboratory-confirmed COVID-19, the mean age was 49.2 years (SD = 15.2), with 68% being men.

KenyaCOVID-19publié 2022PloS onePubMeddocument de 7 observations

52,2 %52.2% of COVID-19 positive DKA patients had moderate DKA.

KenyaCOVID-19 · diabetic ketoacidosis (DKA)observé during COVID-19 pandemicpublié 2024BMC endocrine disordersPubMeddocument de 16 observations

1,37 aORMortality during COVID-19 hospitalization was 37% higher among patients with diabetes (adjusted odds ratio [aOR] 1.37).

KenyaCOVID-19 · diabète (non précisé)publié 2025Global health actionPubMeddocument de 11 observations

73 %Lineage B.1 accounted for 73% of sequenced SARS-CoV-2 infections in Coastal Kenya during Wave 1.

KenyaCOVID-19observé Wave 1publié 2022eLifeeurope_pmcdocument de 6 observations

1,6 %The case fatality rate of COVID-19 in Kenya was 1.6% as of July 30, 2020.

KenyaCOVID-19observé July 30, 2020publié 2022Journal of global healthPubMeddocument de 24 observations

300 transition_eventsASR analysis identified more than 300 virus location transition events during March 2020 to February 2021, comprising 69 viral imports into Coastal Kenya, 93 viral exports from coastal Kenya, and 191 inter-county import/export events.

KenyaCOVID-19observé March 2020 - February 2021publié 2021Transmission networks of SARS-CoV-2 in coastal Kenya during the first two waves: a retrospeurope_pmcdocument de 4 observationsDOI 10.1101/2021.07.01.21259583

23 %Of the 2,568 symptomatic individuals tested, 588 (23%) were SARS-CoV-2 positive by RT-PCR in the Coastal part of Kenya between 17th March 2020 and 30th June 2021.

KenyaCOVID-19observé 17th March 2020 to 30th June 2021publié 2022Wellcome open researcheurope_pmcdocument de 10 observations

5 %The mortality rate was 5% among patients admitted with laboratory-confirmed COVID-19 infection at Aga Khan University Hospital, Nairobi.

KenyaCOVID-19publié 2022PloS onePubMeddocument de 7 observations